Rumänien - Rumänisch - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lek pharmaceuticals d.d. - slovenia - rosuvastatinum - compr. film. - 5mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei

Rumänien - Rumänisch - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lek pharmaceuticals d.d. - slovenia - rosuvastatinum - compr. film. - 10mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei

Rumänien - Rumänisch - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lek pharmaceuticals d.d. - slovenia - rosuvastatinum - compr. film. - 20mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei

Rumänien - Rumänisch - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lek pharmaceuticals d.d. - slovenia - rosuvastatinum - compr. film. - 40mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei

Republik Moldau - Rumänisch - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

teva pharmaceutical industries ltd - piperacillinum + tazobactamum - pulbere pentru solutie perfuzabila - 2 g + 0,25 g

Europäische Union - Rumänisch - EMA (European Medicines Agency)

ecuphar - hidrocortizon aceponat - corticosteroizi, preparate dermatologice - câini - pentru tratamentul simptomatic al dermatozelor inflamatorii și pruritice la câini. for alleviation of clinical signs associated with atopic dermatitis in dogs.

Europäische Union - Rumänisch - EMA (European Medicines Agency)

ecuphar nv - enflicoxib - produse antiinflamatorii și antireumatice - câini - for the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.

Europäische Union - Rumänisch - EMA (European Medicines Agency)

a.c.o.m. - advanced center oncology - cupru (64cu) - radionuclide imaging - various diagnostic radiopharmaceuticals - cuprymina este un precursor radiofarmaceutic. nu este destinat utilizării directe la pacienți. acest medicament trebuie utilizat numai pentru radiomarcarea moleculelor purtătoare care au fost special dezvoltate și autorizate pentru radiomarcare cu acest radionuclid.

Europäische Union - Rumänisch - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

Europäische Union - Rumänisch - EMA (European Medicines Agency)

ecuphar - meloxicamul - anti-inflamatorii și antireumatice produse - dogs; cats - suspensie orală:câini:ameliorarea inflamației și durerii în ambele tulburări musculoscheletale acute și cronice. soluție injectabilă:câini:ameliorarea inflamației și durerii în ambele tulburări musculoscheletale acute și cronice. reducerea durerii postoperatorii și a inflamației după operația ortopedică și a țesuturilor moi. pisici:reducerea durerii post-operatorii dupa ovariohisterectomie și minore țesuturilor moi chirurgie.